COVID-19 testing and its intersections with HIV and hepatitis C
To limit the transmission of the novel coronavirus disease (COVID-19), it is critical to rapidly detect the virus through testing and contact tracing. The Canadian healthcare system must prioritize testing individuals who are the most vulnerable or people who may not access care through traditional health services.
This webinar will provide insight into COVID-19 testing technologies, including their accuracy and limitations, and how COVID-19 testing fits within the landscape of HIV and hepatitis C testing services.
Invited speakers will explore the intersections of HIV, hepatitis C and COVID-19 testing for affected communities, as well as how HIV and hepatitis C testing may change as a result of this new pandemic.
Moderator: Andrew Brett, Director of Communications, CATIE
- Dr. Mel Krajden, Medical Director, British Columbia Centre for Disease Control Public Health Laboratory
- Dr. Alexandra King, Cameco Chair in Indigenous Health, University of Saskatchewan
- Dr. Jeff Powis, Infectious Diseases Physician, Michael Garron Hospital and South Riverdale Community Health Centre
- Chasity Vermette, HIV Nurse Clinician, Positive Care Program, Access Place, Saskatchewan Health Authority
- Dr. Sean Rourke, Scientist, Li Ka Shing Knowledge Institute, St. Michael’s Hospital; Director, CIHR Centre for REACH in HIV/AIDS; Director, CIHR CBR Collaborative Centre